Guardant Health to Participate in the BofA Securities 2021 Healthcare Conference
29 April 2021 - 10:05PM
Business Wire
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology
company, today announced the company will be participating in the
upcoming BofA Securities 2021 Healthcare Conference.
Guardant Health’s management is scheduled to participate in a
fireside chat on Wednesday, May 12 at 2:00 p.m. Pacific Time / 5:00
p.m. Eastern Time. Interested parties may access a live and
archived webcast of the presentation on the “Investors” section of
the company website at: www.guardanthealth.com.
About Guardant Health
Guardant Health is a leading precision oncology company focused
on helping conquer cancer globally through use of its proprietary
blood tests, vast data sets, and advanced analytics. The Guardant
Health oncology platform leverages capabilities to drive commercial
adoption, improve patient clinical outcomes, and lower healthcare
costs across all stages of the cancer care continuum. Guardant
Health has commercially launched liquid biopsy-based Guardant360®,
Guardant360 CDx, and GuardantOMNI® tests for advanced stage cancer
patients, and Guardant Reveal™ test for early-stage cancer
patients. These tests fuel development of its LUNAR screening
program, which aims to address the needs of asymptomatic
individuals eligible for cancer screening and individuals at a
higher risk for developing cancer with early detection.
Source: Guardant Health, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210429005209/en/
Investor Contact: Carrie Mendivil
investors@guardanthealth.com
Media Contact: Anna Czene press@guardanthealth.com
Julie Johnson julie.johnson@uncappedcommunications.com
Guardant Health (NASDAQ:GH)
Historical Stock Chart
From Apr 2024 to May 2024
Guardant Health (NASDAQ:GH)
Historical Stock Chart
From May 2023 to May 2024